Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about $232 million (R4 billion).

Businesses are struggling to make long-term investment decisions amid extreme global and local uncertainty, with temporary market resilience masking deeper economic risks.